Xenon Pharmaceuticals Inc. - Common Stock (XENE)

234 filings reported holding XENE - Xenon Pharmaceuticals Inc. - Common Stock as of Q4 2024.
Xenon Pharmaceuticals Inc. - Common Stock (XENE) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 76.3M shares of 77.3M outstanding shares and own 98.65% of the company stock.
Largest 10 shareholders include FMR LLC (7.53M shares), Avoro Capital Advisors LLC (5.67M shares), Driehaus Capital Management LLC (4.52M shares), WELLINGTON MANAGEMENT GROUP LLP (3.78M shares), BRAIDWELL LP (2.91M shares), JANUS HENDERSON GROUP PLC (2.87M shares), COMMODORE CAPITAL LP (2.74M shares), Polar Capital Holdings Plc (2.7M shares), Capital International Investors (2.55M shares), and Capital World Investors (2.29M shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.